美国Cylex   
Cylex ImmuKnow免疫细胞功能检测方法

Originally founded in 1992, Cylex is a venture-backed global life sciences company based in Columbia, MD USA. Cylex develops, manufactures and commercializes in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. The Company received certification to ISO 13485:2003 and 9001:2000, signifying compliance with internationally recognized standards in design, development and manufacturing of medical products. Cylex experienced exponential growth in recent years and holds a robust portfolio of patents issued in North America, Europe and Asia.

Cylex’s first FDA-cleared product, ImmuKnow, represents patented technology designed to give clinical researchers insight for individualized patient management. Combined with individual patients’ clinical factors and other routine monitoring tests, ImmuKnow assay results help guide decisions in therapy to avoid over- or under-immunosuppression. ImmuKnow is currently sold in over 15 countries.